Princeton Capital Advisors (“PCA”) is a global independent advisory firm that provides innovative, unconflicted and fact-based strategic advice to a diverse client base on many of their most important ...

Founded in 1999, Perceptive Advisors is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologi ...

Preload Therapeutics is pursuing cardiometabolic reprogramming via FGF21 agonism. Preload has in-licensed a late development ready asset: PTX-001 (aka NGM-313/MK-3655) —the only FGF21 agonist antibody ...

The Pangen Fund I GP LLC is seeking to partner with pipeline companies specialized in cell and gene therapy. Our preferred investment rounds are Pre-Seed or Series A, with check sizes typically rangin ...

Palo Santo is an early-stage venture firm dedicated to advancing the next generation of neuroscience and mental-health therapeutics.

PEACCEL is a DeepTech company pioneering AI- and Quantum-driven drug discovery. Its proprietary innov’SAR™ platform integrates generative AI, ML, DL, and early Quantum Machine Learning to engineer hig ...

Performance Medical Technologies is a drug development company located in Charlottesville, VA and Trieste, Italy focused on validating and commercializing a new therapeutic for early stage Parkinson's ...

PNR Ventures is a Boston-based provider of global strategic advisory services to life science companies across pharma, biotech, and medical devices. We leverage our own company creation, investment, a ...

Programmable Medicine is a clinical stage company with a transformative nanomedicine technology exclusively licensed from Johns Hopkins University. The nanomedicine, hydroxyl dendrimers (HDs), precise ...